Search clinical trials for: dapsone 5% gel

Total 10582 results

Allergan

Completed

A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

Rosacea

United States
Vanderbilt University Medical Center

Terminated

Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis

Dermatitis Herpetiformis

United States
Allergan

Completed

Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

Acne Vulgaris

United States
Allergan

Withdrawn

An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

Acne Vulgaris
Allergan

Withdrawn

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

Acne Vulgaris
Torrent Pharmaceuticals Limited
Catawba Research

Completed

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Almirall, S.A.
Allergan

Completed

Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Bausch Health Americas, Inc.

Completed

A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Photoallergy Potential of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Almirall, S.A.
Allergan

Completed

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Canada
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Canada
Allergan

Completed

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Dermal Tolerability of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Allergan

Terminated

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Rash | Non-small-Cell Lung Cancer

United States
Seegpharm S.A.

Completed

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Allergan

Completed

A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%

Acne Vulgaris
John H. Stroger Hospital

Unknown

Dapsone Prurigo Study

Lichen Simples Chronicus and Prurigo

United States
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Completed

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Cetuximab-induced Papulopustular (Acneiform) Rash Who Have | Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma

United States
Ralexar Therapeutics, Inc.

Unknown

Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States, Canada
Lakewood-Amedex Inc
PrimeVigilance; Professional Education and Research Institute

Terminated

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Chronic Diabetic Foot Ulcers

United States
Ralexar Therapeutics, Inc.

Completed

A Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis | Eczema, Atopic

United States
Assiut University

Not yet recruiting

DAPSONE GEL7.5%Versus Trichloroacetic Acid 20% ON ACNE VULGARIS

Acne Vulgaris
Dermata Therapeutics

Completed

DMT210 Topical Gel in the Treatment of Acne Rosacea

Acne Rosacea

United States
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Acne Vulgaris

United States
Allergan

Completed

A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

Acne Vulgaris

United States
Flavia Pardo Salata Nahsan

Completed

Potassium Oxalate and Placebo and Post-bleaching Sensitivity

Medicaments Substances in Therapeutic Use

Brazil
Derm Research, PLLC

Completed

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

Acne

United States
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaborators

Completed

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

HIV Infections

United States, Malawi, South Africa, Zambia, Zimbabwe
Universidade Federal de Sergipe

Completed

Potassium Oxalate and Potassium Nitrate and Post-bleaching Sensitivity

Medicaments Substances in Therapeutic Use

Brazil
Allergan

Completed

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Acne Vulgaris

United States
Lakewood-Amedex Inc

Not yet recruiting

Nu-3 Gel for Infected Diabetic Foot Ulcers

Diabetic Foot Infection
Mahidol University

Withdrawn

A Study of Efficacy of Benzoyl Peroxide Regimens in Treatment of Unpleasant Foot Odor

Foot Dermatoses | Benzoyl Peroxide

Thailand
Botanix Pharmaceuticals

Completed

A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

United States
Medical University of Silesia

Recruiting

CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)

Bruxism | Myofascial Pain | Temporomandibular Disorder | CBD | Orofacial Pain

Poland
Allergan

Completed

Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency

Acne Vulgaris

United States
Cosmetique Active International

Completed

Efficacy and Tolerance of Formula 609613 37 in Acneic Patients

Acne
Botanix Pharmaceuticals

Completed

A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

Hyperhidrosis

United States
Abbott Medical Devices

Completed

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) (PROTECT)

Carotid Artery Disease

United States
Universidade Federal do Para

Completed

Effect of Glutaraldehyde on Dentin Hypersensitivity After Non-surgical Periodontal Treatment

Dentin Sensitivity

Brazil
King Abdulaziz University

Not yet recruiting

The Assessment of Clinical Efficacy of Topical Application of 5% Thymoquinone Gel for Gingivitis Patients

Gingivitis

Saudi Arabia
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaborators

Completed

Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India

HIV Infections
Vaxart

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Condyloma

Argentina, Chile, Ecuador, Serbia
bioRASI, LLC

Completed

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

Papulopustular Rosacea | Erythematotelangiectatic Rosacea

United States
Jinnah Postgraduate Medical Centre

Completed

Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris

Acne Vulgaris

Pakistan
University of Southern California

Completed

Topical Treatment and Prevalence of P. Acnes

Surgical Site Infection

United States
MediWound Ltd

Completed

A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers

Venous Leg Ulcer

United States, Switzerland
Zydus Lifesciences Limited

Completed

To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

Acne Vulgaris

United States, India
Derm Research, PLLC
WFH MEDICAL, LLC

Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Acne Vulgaris

United States

3

Subscribe